Could a magnetic helmet curb impulsivity in veterans with ADHD?

NCT ID NCT07442058

Not yet recruiting Symptom relief Sponsor: VA Office of Research and Development Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 23, 2026 · Updated 3 times

Summary

This study tests a new, non-drug treatment for veterans with ADHD who still struggle with impulsivity despite medication. The treatment, called intermittent theta-burst stimulation (iTBS), uses magnetic pulses to gently stimulate brain areas linked to self-control. Thirty-five veterans will receive either real or sham stimulation to see if the approach is feasible and acceptable.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Intermittent Theta-Burst Stimulation (iTBS), a type of transcranial magnetic stimulation
What this could lead to: If it works, this could point toward a drug-free way to help veterans with ADHD manage impulsivity and improve daily functioning.
What could go wrong: This is a very early, small feasibility study with only 35 participants. It is not yet recruiting, and the main goal is to see if the treatment is acceptable, not whether it works. There is also a risk that the sham (placebo) group shows similar results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder Impulsive Behavior

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY

Contacts and locations

Locations

Providence VA Medical Center, Providence, RI

Providence, Rhode Island, 02908-4734, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.